StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance Shares of GNCA stock opened at $0.00 on Thursday. The company has a debt-to-equity ratio of 0.24, a current ratio of […]